Indapamidă Terapia (Indapamide)

Indapamide blocks the Na+/Cl‑ cotransporter in the distal convoluted tubule of the kidney. This inhibition reduces reabsorption of sodium and chloride, leading to increased urinary loss of these ions together with water. The resulting decrease in extracellular fluid volume lowers cardiac preload and systemic vascular resistance, which helps to lower arterial pressure.

The exact dose of Indapamidă Terapia is determined by the prescribing clinician based on the individual’s medical condition, response to therapy, and renal function. Typical adult dosing ranges are described in the product’s prescribing information, but the prescriber will set the appropriate regimen for each patient.

Safety data for indapamide in pregnancy are limited, and the drug should only be used if the potential benefit justifies any potential risk to the fetus. It is excreted in breast milk, so caution is advised for nursing mothers, and a healthcare professional should evaluate the risk‑benefit balance before continuation.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, and will request verification of trade or institutional credentials. After confirmation, the team provides pricing, availability, shipping details (including any cold‑chain needs) and assists with import documentation.

Indapamide and hydrochlorothiazide belong to the same thiazide‑like class, but indapamide often has a longer duration of action and may cause fewer metabolic disturbances, such as less impact on potassium levels. Both lower blood pressure by promoting natriuresis, yet individual response and tolerability can differ, so clinicians choose based on patient profile and therapeutic goals.

Indapamidă Terapia should be stored at room temperature, below 25 °C. Keep the product in its original packaging, protect it from moisture and direct sunlight, and ensure the container is tightly closed to maintain stability throughout its shelf life.

The medication is taken orally, usually with a full glass of water. It can be taken with or without food, but patients should follow the prescriber’s instructions regarding timing and whether to take it in the morning to reduce the likelihood of nocturnal urination.

Serious adverse events include severe dehydration, electrolyte imbalances such as hyponatremia or hypokalemia, hyperuricemia leading to gout attacks, and rare blood disorders like leukopenia or thrombocytopenia. Patients should be educated to report symptoms such as dizziness, muscle cramps, rapid weight loss, or unusual bruising promptly.

Indapamidă Terapia is contraindicated in patients with known hypersensitivity to indapamide or any thiazide‑like diuretic, severe renal impairment, anuria, or uncontrolled electrolyte disturbances. Caution is also advised for individuals with a history of gout, severe liver disease, or those taking interacting medications such as lithium without close monitoring.